Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

OnCore Login
Login to Oncore Network

Login to Oncore Network

Hoosier Cancer Research Network on Facebook

Hoosier Cancer Research Network on Facebook

GU14-182

A Randomized, Double-Blinded, Phase II Study of Maintenance Pembrolizumab versus Placebo after First-line Chemotherapy in Patients with Metastatic Urothelial Cancer: HCRN GU14-182

Status: Open to Accrual

This is a multi-institutional, randomized, placebo controlled, double-blinded phase II trial of maintenance pembrolizumab versus placebo after first-line chemotherapy in patients with metastatic urothelial cancer who have achieved at least stable disease on first-line chemotherapy.

  • Condition: Urothelial Cancer, Bladder Cancer
  • Intervention:
    • Drug: Pembrolizumab
    • Other: Placebo
  • Phase: Phase 2

For full description, see www.clinicaltrials.gov.

Read news release about this trial.

Watch a video about this trial:

Project Manager: Dana Musapatika, dmusapatika@hoosiercancer.org; (317) 634-5842, ext. 39.